A European clinical trial which will evaluate four experimental treatments for the novel coronavirus began Sunday, with at least 800 patients in France who have severe forms of the disease expected to take part.

The announcement came from the French National Institute of Health and Medical Research (Inserm), the coordinating body.

The trial, called Discovery, is being led by Florence Ader, an infectious disease specialist in the Infectious and Tropical Diseases Department of Croix-Rousse Hospital in Lyon, who said that a number of antiviral molecules are being tested: remdesivir, lopinavir and ritonavir in combination, the latter being administered with

Read more: Clinical trial starts in France for treating COVID-19